ArticleTurk psikiyatri dergisi = Turkish journal of psychiatry2025
A Case of Pseudotumor Cerebri Associated with Lithium Use.
Article in Turk psikiyatri dergisi = Turkish journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudotumor cerebri (PC), also known as idiopathic intracranial hypertension, is characterized by increased intracranial pressure in the presence of normal brain imaging and cerebrospinal fluid analysis. Papilledema, headache and visual loss are frequently observed clinical signs and symptoms. Although the pathogenesis of pseudotumor cerebri is not known exactly, different risk factors have been identified. Drugs such as growth hormone, tetracycline and retinoic acid have been reported to be associated with PC. Additionally, in the literature, there are case reports indicating the development of PC associated with lithium use. The aim of this case report is to discuss a 26-year-old patient who was started on lithium with a diagnosis of bipolar disorder and presented to the emergency service with complaints of headache and visual loss 4 months after the initiation of treatment and was diagnosed with PC associated with lithium use. It is important to be aware of the risk of PC development in patients treated with lithium and to rapidly evaluate patients in this respect in case of clinical symptoms such as headache and vision problems because of the risk of permanent vision loss. Keywords: Intracranial Hypertension, Lithium, Papilledema, Pseudotumor Cerebri.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.